查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2141748

獸用麻醉劑市場：全球市場預測，2026-2032年

Veterinary Anesthetic Drugs Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸用麻醉劑市場將成長至 30.8 億美元，複合年成長率為 7.20%。

主要市場統計數據
基準年 2025 18.9億美元
預計年份：2026年 20億美元
預測年份 2032 30.8億美元
複合年成長率 (%) 7.20%

獸用麻醉劑：概述

獸用麻醉劑用於伴侶動物、家畜、馬匹和實驗動物的鎮靜、誘導、維持、鎮痛和恢復。其需求受多種因素影響，包括外科手術、急診、預防性治療、動物福利期望、監管要求以及獲得訓練有素的獸醫專業人員的機會。臨床選擇取決於動物種類、年齡、健康狀況、手術時間、監測能力和恢復需求。

安全、福利和規程設計正在改變我們行醫的方式。

獸醫團隊正朝著更個人化的麻醉方案發展，這些方案結合了術前用藥、多方面鎮痛、精準給藥、主動監測和系統化的恢復過程。人們對動物福利的日益關注推動了疼痛評估、減少動物壓力操作以及清晰記錄麻醉風險等方面的發展。供應的連續性、產品授權、管制藥品法規、儲存要求和培訓仍然是重要的營運考量因素，尤其是在處理多種動物或監測能力有限的診所中。

人工智慧（AI）增強了風險評估和工作流程支援。

人工智慧可以輔助進行麻醉前風險分層、劑量驗證、生理趨勢分析、記錄保存、庫存規劃以及識別需要密切觀察的患者。其最可靠的功能在於決策支持，而非自主處方。獸醫必須根據物種特異性藥理學、臨床試驗、當地法規以及患者的即時反應來驗證輸出結果。因此，在實施過程中，應優先考慮資料安全管理、可解釋性、與臨床系統的整合以及對模型效能的正式檢驗。

區域洞察：醫療資源取得差異與先進臨床技術

在北美，先進的監測系統、轉診至專科醫生的機制以及全面的伴侶動物照護體系已經建立，同時對藥品和管制物質也實施嚴格的管控。在歐洲，動物福利、法規遵循和標準化臨床實踐備受重視，歐盟也增加了對跨境授權和供應鏈的考量。在亞太地區，儘管獸醫系統高度發達，都市區寵物護理服務也在迅速發展，但農村地區的醫療資源取得和人員配備方面仍存在顯著差異。拉丁美洲的特點是伴侶動物服務不斷擴展，農業領域的需求旺盛，但獲得專業麻醉支持的機會卻存在差距。在中東，需求主要集中在都市區獸醫中心、馬匹護理和轉診機構，而非洲則面臨藥物、醫療設備、訓練有素的人員和特定物種服務方面更為廣泛的差距。

群體特定洞察：政策協調與醫療保健系統影響實施

東協市場管理體制多樣，都市區寵物飼養量不斷成長，獸醫監管和培訓機會不均。金磚國家動物數量大規模，公共衛生、農業和伴侶動物等領域的優先事項各不相同，使得分銷和人力資源發展成為核心挑戰。歐盟致力於協調監管原則，同時保留各國在臨床服務上的差異。七國集團（G7）國家普遍擁有成熟的獸醫基礎設施、嚴格的安全標準，並廣泛採用先進的監測技術。海灣合作理事會（GCC）市場專注於現代化的都市區診所、轉診服務以及馬匹和牲畜的應用。北約成員國的獸醫體系各不相同，緊急應變能力、服務性動物照護、法規和臨床互通性等因素都會影響採購和訓練。

針對特定國家的見解：當地法規和臨床基礎設施至關重要。

儘管地理遼闊，面臨許多挑戰，澳洲和加拿大仍建立了完善的獸醫服務體系，並擁有重要的畜牧業和伴侶動物產業。美國擁有發達的專科和急診醫療系統，而墨西哥的都市區服務不斷擴展，但各地區的服務覆蓋範圍不平衡。巴西和阿根廷受大規模的農業部門和日益成長的伴侶動物照護需求的影響。俄羅斯的醫療體系地域分佈高度分散，並反映了監管的考量。中國、印度、日本和韓國在醫療基礎設施、法律規範和動物照護服務提供方式方面有顯著差異，都市區的監管力道普遍較高。法國、德國、義大利、西班牙和英國高度重視動物福利、專業標準和合理用藥，但在採購系統和獸醫實踐方面仍有明顯差異。

獸醫行業領導者應優先考慮的事項

領導者應圍繞物種特異性安全性、可預測的供應和明確的臨床定位來設計產品系列，而不是依賴單一方案或給藥環境。教育投入應涵蓋劑量、呼吸道管理、監測、鎮痛、恢復和不利事件報告，並應提供適合當地醫療專業人員能力的培訓材料。各機構應加強受目標產品的品管體系，維護穩健的經銷系統，並確保與監測和臨床管理技術的兼容性。在實施人工智慧時，應明確界定其範圍，首先從可審計的工作流程入手，並使獸醫能夠繼續發揮其作為負責任的決策者的作用。與診所、教育機構、監管機構和動物福利組織合作，有助於負責任地實施人工智慧，並發現尚未滿足的需求。

調查方法：基於證據的市場評估

本執行摘要系統地回顧了獸用麻醉劑的現狀，重點關注臨床應用案例、目標動物種類、法規環境、獸醫能力、動物福利期望、技術應用以及區域運營狀況。研究結果對北美、拉丁美洲、歐洲、中東和非洲以及亞太全部區域進行了定性整合，並與東協、金磚國家、歐盟、七國集團、海灣合作理事會、北約成員國以及指定國家進行了比較。該評估避免了未經證實的市場量化，並區分了已建立的臨床趨勢和需要現場檢驗的領域。

結論：更安全、更協調的麻醉護理

獸用麻醉劑在各種動物群體的外科手術、診斷、急診和人道治療中繼續發揮核心作用。更安全的操作規程、更強的鎮痛效果、更完善的監測、更嚴格的監管以及更一體化的臨床工作流程正在引領實踐的發展方向。由於獲取途徑仍然存在不平等，成功的策略必須將產品品質與培訓、穩定的供應、本地合規性以及可操作的決策支援相結合。人工智慧如果以透明的方式並在獸醫的監督下實施，則可以促進這些目標的實現。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用麻醉劑市場：依藥物類型分類

  • 吸入麻醉劑
    • DESFLURANE
    • Isoflurane
    • SEVOFLURANE
  • 注射麻醉劑
    • α-2促效劑
    • 巴比妥酸鹽藥
      • Pentobarbital
      • Phenobarbital
      • 硫噴妥鈉
    • 分離性麻醉劑
      • 氯胺酮
      • 替來他明/唑拉西泮
    • 鴉片類鎮痛藥
      • Butorphanol
      • Fentanyl
      • 氫可酮
  • 局部麻醉劑
    • Lidocaine
    • Prilocaine
    • 丁卡因

第8章 獸用麻醉劑市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
    • 小型哺乳動物
  • 馬
    • 挽馬
    • 小馬
    • 純種馬
  • 家畜
    • 牛
    • 家禽
    • 豬

第9章 獸用麻醉劑市場：依給藥途徑分類

  • 吸入
    • 氣管插管
    • 面具
  • 肌肉內部
  • 靜脈
  • 皮下
  • 外用

第10章 獸用麻醉劑市場：依劑型分類

  • 氣體
  • 液體
    • 水溶液
    • 乳液

第11章 獸用麻醉劑市場：依最終用戶分類

  • 研究所
  • 動物診所
  • 動物醫院

第12章 獸用麻醉劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸用麻醉劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸用麻醉劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Animalcare Group plc
  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Chanelle Pharma Group
  • Covetrus, Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Henry Schein Animal Health
  • Huvepharma NV
  • IDEXX Laboratories, Inc.
  • Jurox Pty Ltd.
  • Merck & Co., Inc.
  • MWI Veterinary Supply Co.
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Orion Corporation
  • Patterson Companies, Inc.
  • VetOne
  • Vetoquinol SA
  • Virbac SA
  • Wedgewood Pharmacy
  • Zoetis Inc.

第17章 主要專家

Product Code: MRR-9C4233EE5E6C

The Veterinary Anesthetic Drugs Market is projected to grow by USD 3.08 billion at a CAGR of 7.20% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.89 billion
Estimated Year [2026] USD 2.00 billion
Forecast Year [2032] USD 3.08 billion
CAGR (%) 7.20%

Veterinary Anesthetic Drugs: Executive Overview

Veterinary anesthetic drugs support sedation, induction, maintenance, analgesia, and recovery across companion-animal, livestock, equine, and laboratory-animal care. Demand is shaped by surgical activity, emergency medicine, preventive procedures, animal-welfare expectations, regulatory requirements, and access to trained veterinary professionals. Clinical selection depends on species, age, health status, procedure length, monitoring capacity, and recovery needs.

Safety, Welfare, and Protocol Design Are Reshaping Practice

Veterinary teams are moving toward more individualized anesthetic protocols that combine premedication, multimodal analgesia, precise dosing, active monitoring, and structured recovery. Greater attention to animal welfare is encouraging pain assessment, lower-stress handling, and clearer documentation of anesthetic risk. Supply continuity, product authorization, controlled-substance rules, storage requirements, and training remain important operational considerations, particularly where clinics serve diverse species or have limited monitoring infrastructure.

Artificial Intelligence Strengthens Risk Assessment and Workflow Support

Artificial intelligence can assist with pre-anesthetic risk stratification, dose-checking, physiologic trend analysis, documentation, inventory planning, and identification of patients requiring closer observation. Its most credible role is decision support rather than autonomous prescribing: veterinarians must validate outputs against species-specific pharmacology, clinical examination, local regulations, and real-time patient response. Implementation should therefore prioritize secure data practices, explainability, integration with practice systems, and formal review of model performance.

Regional Insights: Uneven Access Meets Rising Clinical Sophistication

North America combines advanced monitoring, specialist referral capacity, and strong companion-animal care with stringent controls over pharmaceuticals and controlled substances. Europe emphasizes animal welfare, regulatory compliance, and standardized clinical practice, while the European Union adds cross-border authorization and supply-chain considerations. Asia-Pacific spans highly developed veterinary systems and rapidly expanding urban pet care, alongside substantial variation in rural access and workforce capacity. Latin America is characterized by growing companion-animal services, agricultural demand, and uneven access to specialist anesthesia support. The Middle East shows concentrated demand around urban veterinary centers, equine care, and referral facilities, while Africa faces wider disparities in medicines, equipment, trained personnel, and species-specific services.

Group Insights: Policy Alignment and Healthcare Capacity Shape Adoption

ASEAN markets reflect diverse regulatory systems, expanding urban pet ownership, and differing access to veterinary monitoring and training. BRICS economies combine large animal populations with varied public-health, agricultural, and companion-animal priorities, making distribution and workforce development central issues. The European Union supports harmonized regulatory principles while retaining national differences in clinical delivery. G7 countries generally have mature veterinary infrastructure, robust safety expectations, and greater availability of advanced monitoring. GCC markets emphasize modern urban clinics, referral medicine, and equine and livestock applications. NATO members represent a broad set of veterinary systems where preparedness, service-animal care, regulation, and clinical interoperability can influence procurement and training.

Country Insights: Local Regulation and Clinical Infrastructure Matter

Australia and Canada combine broad geographic coverage challenges with established veterinary services and important livestock and companion-animal applications. The United States has extensive specialty and emergency capacity, while Mexico is characterized by expanding urban services alongside regional variation in access. Brazil and Argentina are influenced by large agricultural sectors and growing companion-animal care; Russia's system reflects substantial geographic dispersion and regulatory considerations. China, India, Japan, and South Korea differ markedly in healthcare infrastructure, regulatory pathways, and animal-care delivery, with urban centers generally offering more advanced monitoring. France, Germany, Italy, Spain, and the United Kingdom place strong emphasis on welfare, professional standards, and regulated medicine use, while national procurement and practice patterns remain distinct.

Recommended Priorities for Veterinary Industry Leaders

Leaders should design portfolios around species-specific safety, predictable supply, and clear clinical positioning rather than relying on a single protocol or administration setting. Investments in education should cover dosing, airway management, monitoring, analgesia, recovery, and adverse-event reporting, with materials adapted to local workforce capability. Organizations should strengthen quality systems for controlled products, maintain resilient distribution, and support compatibility with monitoring and practice-management technologies. AI initiatives should begin with narrowly defined, auditable workflows and retain veterinarians as accountable decision-makers. Partnerships with clinics, teaching institutions, regulators, and animal-welfare organizations can improve responsible adoption and identify unmet training needs.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses a structured review of the veterinary anesthetic-drug landscape, focusing on clinical use cases, species coverage, regulatory context, veterinary capacity, welfare expectations, technology adoption, and regional operating conditions. Findings are synthesized qualitatively across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with additional comparison of ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings and the specified countries. The assessment avoids unsupported market quantification and distinguishes established practice trends from areas requiring local validation.

Conclusion: Safer, More Connected Anesthesia Practice

Veterinary anesthetic drugs remain central to surgery, diagnostics, emergency care, and humane treatment across diverse animal populations. The direction of practice is being defined by safer protocols, stronger analgesia, better monitoring, regulatory discipline, and more integrated clinical workflows. Access remains uneven, so successful strategies must pair product quality with training, resilient supply, local compliance, and practical decision support. Artificial intelligence can reinforce these objectives when deployed transparently and under veterinary oversight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Anesthetic Drugs Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Inhalation Anesthetic
    • 7.2.1. Desflurane
    • 7.2.2. Isoflurane
    • 7.2.3. Sevoflurane
  • 7.3. Injectable Anesthetic
    • 7.3.1. Alpha-2 Agonists
    • 7.3.2. Barbiturates
      • 7.3.2.1. Pentobarbital
      • 7.3.2.2. Phenobarbital
      • 7.3.2.3. Thiopental
    • 7.3.3. Dissociatives
      • 7.3.3.1. Ketamine
      • 7.3.3.2. Tiletamine-Zolazepam
    • 7.3.4. Opioid Analgesics
      • 7.3.4.1. Butorphanol
      • 7.3.4.2. Fentanyl
      • 7.3.4.3. Morphine
  • 7.4. Topical Anesthetic
    • 7.4.1. Lidocaine
    • 7.4.2. Prilocaine
    • 7.4.3. Tetracaine

8. Veterinary Anesthetic Drugs Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Companion Animals
    • 8.2.1. Cats
    • 8.2.2. Dogs
    • 8.2.3. Small Mammals
  • 8.3. Equine
    • 8.3.1. Draft Horse
    • 8.3.2. Pony
    • 8.3.3. Thoroughbred
  • 8.4. Livestock
    • 8.4.1. Cattle
    • 8.4.2. Poultry
    • 8.4.3. Swine

9. Veterinary Anesthetic Drugs Market, by Administration Route

  • 9.1. Introduction
  • 9.2. Inhalation
    • 9.2.1. Intubation
    • 9.2.2. Mask
  • 9.3. Intramuscular
  • 9.4. Intravenous
  • 9.5. Subcutaneous
  • 9.6. Topical

10. Veterinary Anesthetic Drugs Market, by Formulation

  • 10.1. Introduction
  • 10.2. Gas
  • 10.3. Liquid
    • 10.3.1. Aqueous
    • 10.3.2. Emulsion

11. Veterinary Anesthetic Drugs Market, by End User

  • 11.1. Introduction
  • 11.2. Research Laboratories
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. Veterinary Anesthetic Drugs Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Veterinary Anesthetic Drugs Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Veterinary Anesthetic Drugs Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Animalcare Group plc
  • 16.2. Bayer AG
  • 16.3. Bimeda Animal Health
  • 16.4. Boehringer Ingelheim Animal Health USA Inc.
  • 16.5. Ceva Sante Animale
  • 16.6. Chanelle Pharma Group
  • 16.7. Covetrus, Inc.
  • 16.8. Dechra Pharmaceuticals PLC
  • 16.9. Elanco Animal Health Incorporated
  • 16.10. Henry Schein Animal Health
  • 16.11. Huvepharma NV
  • 16.12. IDEXX Laboratories, Inc.
  • 16.13. Jurox Pty Ltd.
  • 16.14. Merck & Co., Inc.
  • 16.15. MWI Veterinary Supply Co.
  • 16.16. Neogen Corporation
  • 16.17. Norbrook Laboratories Limited
  • 16.18. Orion Corporation
  • 16.19. Patterson Companies, Inc.
  • 16.20. VetOne
  • 16.21. Vetoquinol S.A.
  • 16.22. Virbac SA
  • 16.23. Wedgewood Pharmacy
  • 16.24. Zoetis Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Veterinary Anesthetic Drugs Market, Years Considered for the Study
  • FIGURE 2. Global Veterinary Anesthetic Drugs Market, Research Design
  • FIGURE 3. Global Veterinary Anesthetic Drugs Market, Research Framework
  • FIGURE 4. Global Veterinary Anesthetic Drugs Market, Data Triangulation
  • FIGURE 5. Global Veterinary Anesthetic Drugs Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Veterinary Anesthetic Drugs Market Size, by Drug Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Veterinary Anesthetic Drugs Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Veterinary Anesthetic Drugs Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Veterinary Anesthetic Drugs Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Veterinary Anesthetic Drugs Market Size, by Administration Route, 2025 vs 2032 (%)
  • FIGURE 11. Global Veterinary Anesthetic Drugs Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Veterinary Anesthetic Drugs Market Size, by Formulation, 2025 vs 2032 (%)
  • FIGURE 13. Global Veterinary Anesthetic Drugs Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Veterinary Anesthetic Drugs Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Veterinary Anesthetic Drugs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Veterinary Anesthetic Drugs Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Veterinary Anesthetic Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Veterinary Anesthetic Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Veterinary Anesthetic Drugs Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Veterinary Anesthetic Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Veterinary Anesthetic Drugs Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Veterinary Anesthetic Drugs Market Segmentation & Coverage
  • TABLE 2. Global Veterinary Anesthetic Drugs Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 4. Global Inhalation Anesthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Inhalation Anesthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Inhalation Anesthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Desflurane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Desflurane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Desflurane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Isoflurane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Isoflurane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Isoflurane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Sevoflurane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Sevoflurane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Sevoflurane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Injectable Anesthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Injectable Anesthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Injectable Anesthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Alpha-2 Agonists Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Alpha-2 Agonists Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Alpha-2 Agonists Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Barbiturates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Barbiturates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Barbiturates Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Pentobarbital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Pentobarbital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Pentobarbital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Phenobarbital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Phenobarbital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Phenobarbital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Thiopental Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Thiopental Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Thiopental Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Dissociatives Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Dissociatives Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Dissociatives Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Ketamine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Tiletamine-Zolazepam Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Tiletamine-Zolazepam Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Tiletamine-Zolazepam Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Opioid Analgesics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Butorphanol Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Butorphanol Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Butorphanol Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Fentanyl Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Fentanyl Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Fentanyl Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Morphine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Morphine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Morphine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Topical Anesthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Topical Anesthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Topical Anesthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Lidocaine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Lidocaine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Lidocaine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Prilocaine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Prilocaine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Prilocaine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Tetracaine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Tetracaine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Tetracaine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 68. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Cats Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Cats Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Cats Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Small Mammals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Small Mammals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Small Mammals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Draft Horse Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Draft Horse Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Draft Horse Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Pony Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Pony Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Pony Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Thoroughbred Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Thoroughbred Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Thoroughbred Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Swine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Swine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Swine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 105. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Intubation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Intubation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Intubation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Mask Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Global Mask Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. Global Mask Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 114. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 115. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 117. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 120. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 122. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 123. Global Topical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. Global Topical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 125. Global Topical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 126. Global Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 127. Global Gas Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Global Gas Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. Global Gas Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 130. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 132. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 133. Global Aqueous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Global Aqueous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. Global Aqueous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 136. Global Emulsion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 137. Global Emulsion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 138. Global Emulsion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 139. Global Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 143. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 144. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 146. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 147. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 148. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 149. Global Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 150. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 151. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 152. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 153. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 154. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 155. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 156. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 157. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 158. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 159. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 160. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 161. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 162. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 163. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 164. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 165. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 166. Asia-Pacific Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 167. North America Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 168. North America Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 169. North America Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 170. North America Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 171. North America Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 172. North America Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 173. North America Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 174. North America Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 175. North America Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 176. North America Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 177. North America Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 178. North America Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 179. North America Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 180. North America Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 181. North America Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 182. North America Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 183. North America Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 184. Latin America Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 185. Latin America Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 186. Latin America Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 187. Latin America Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 188. Latin America Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 189. Latin America Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 190. Latin America Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 191. Latin America Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 192. Latin America Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 193. Latin America Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 194. Latin America Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 195. Latin America Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 196. Latin America Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 197. Latin America Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 198. Latin America Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 199. Latin America Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 200. Latin America Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. Europe Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 202. Europe Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 203. Europe Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 204. Europe Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 205. Europe Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 206. Europe Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 207. Europe Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 208. Europe Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 209. Europe Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 210. Europe Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 211. Europe Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 212. Europe Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 213. Europe Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 214. Europe Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 215. Europe Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 216. Europe Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 217. Europe Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 218. Middle East Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 219. Middle East Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 220. Middle East Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 221. Middle East Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 222. Middle East Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 223. Middle East Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 224. Middle East Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 225. Middle East Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 226. Middle East Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 227. Middle East Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 228. Middle East Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 229. Middle East Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 230. Middle East Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 231. Middle East Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 232. Middle East Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 233. Middle East Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 234. Middle East Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 235. Africa Veterinary Anesthetic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 236. Africa Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 237. Africa Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 238. Africa Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 239. Africa Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 240. Africa Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 241. Africa Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 242. Africa Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 243. Africa Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 244. Africa Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 245. Africa Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 246. Africa Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 247. Africa Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 248. Africa Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 249. Africa Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 250. Africa Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 251. Africa Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. Global Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 253. ASEAN Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 254. ASEAN Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 255. ASEAN Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 256. ASEAN Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 257. ASEAN Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 258. ASEAN Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 259. ASEAN Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 260. ASEAN Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 261. ASEAN Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 262. ASEAN Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 263. ASEAN Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 264. ASEAN Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 265. ASEAN Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 266. ASEAN Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 267. ASEAN Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 268. ASEAN Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 269. ASEAN Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. GCC Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 271. GCC Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 272. GCC Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 273. GCC Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 274. GCC Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 275. GCC Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 276. GCC Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 277. GCC Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 278. GCC Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 279. GCC Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 280. GCC Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 281. GCC Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 282. GCC Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 283. GCC Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 284. GCC Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 285. GCC Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 286. GCC Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 287. European Union Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 288. European Union Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 289. European Union Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 290. European Union Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 291. European Union Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 292. European Union Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 293. European Union Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 294. European Union Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 295. European Union Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 296. European Union Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 297. European Union Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 298. European Union Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 299. European Union Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 300. European Union Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 301. European Union Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 302. European Union Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 303. European Union Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 304. BRICS Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 305. BRICS Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 306. BRICS Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 307. BRICS Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 308. BRICS Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 309. BRICS Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 310. BRICS Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 311. BRICS Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 312. BRICS Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 313. BRICS Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 314. BRICS Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 315. BRICS Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 316. BRICS Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 317. BRICS Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 318. BRICS Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 319. BRICS Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 320. BRICS Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 321. G7 Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 322. G7 Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 323. G7 Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 324. G7 Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 325. G7 Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 326. G7 Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 327. G7 Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 328. G7 Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 329. G7 Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 330. G7 Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 331. G7 Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 332. G7 Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 333. G7 Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 334. G7 Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 335. G7 Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 336. G7 Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 337. G7 Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 338. NATO Veterinary Anesthetic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 339. NATO Veterinary Anesthetic Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 340. NATO Veterinary Anesthetic Drugs Market Size, by Inhalation Anesthetic, 2017-2032 (USD Million)
  • TABLE 341. NATO Veterinary Anesthetic Drugs Market Size, by Injectable Anesthetic, 2017-2032 (USD Million)
  • TABLE 342. NATO Veterinary Anesthetic Drugs Market Size, by Barbiturates, 2017-2032 (USD Million)
  • TABLE 343. NATO Veterinary Anesthetic Drugs Market Size, by Dissociatives, 2017-2032 (USD Million)
  • TABLE 344. NATO Veterinary Anesthetic Drugs Market Size, by Opioid Analgesics, 2017-2032 (USD Million)
  • TABLE 345. NATO Veterinary Anesthetic Drugs Market Size, by Topical Anesthetic, 2017-2032 (USD Million)
  • TABLE 346. NATO Veterinary Anesthetic Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 347. NATO Veterinary Anesthetic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 348. NATO Veterinary Anesthetic Drugs Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 349. NATO Veterinary Anesthetic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 350. NATO Veterinary Anesthetic Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 351. NATO Veterinary Anesthetic Drugs Market Size, by Inhalation, 2017-2032 (USD Million)
  • TABLE 352. NATO Veterinary Anesthetic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 353. NATO Veterinary Anesthetic Drugs Market Size, by Liquid, 2017-2032 (USD Million)
  • TABLE 354. NATO Veterinary Anesthetic Drugs Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 355. Global Veterinary Anesthetic Drugs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 356. United States Veterinar